The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.10
Bid: 3.00
Ask: 3.20
Change: -0.20 (-6.06%)
Spread: 0.20 (6.667%)
Open: 3.30
High: 3.47
Low: 3.10
Prev. Close: 3.30
TERN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tern PLC: New commercial order for FundamentalVR

4 Dec 2019 07:01

Tern PLC (TERN) Tern PLC: New commercial order for FundamentalVR 04-Dec-2019 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

4 December 2019

Tern Plc ("Tern" or the "Company")

New commercial order for FundamentalVR

 

Tern Plc (AIM: TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that FVRVS Limited ("FundamentalVR"), a leading virtual reality ("VR") training and data analysis technology platform, and one of Tern's existing portfolio companies, has secured a significant new contract (£0.5 million) to create a Virtual Reality Haptic Simulation platform for a new customer, which is a global pharmaceutical company ("the Client").  

 

This is the first of a planned series of virtual reality simulations to be designed by FundamentalVR to support the Client's ambitions to accelerate the safe and compliant use of their products. This order to configure the Fundamental platform for a surgical procedure is expected to be completed during 2020. FundamentalVR's technology is now being used by an array of customer groups including:

 

Clinics/ medical centres Device companies Pharmaceutical companies

 

FundamentalVR's award winning platform combines immersive VR with cutting-edge haptics (the sense of touch) to create low-cost, measurable and scalable simulation experiences. FundamentalVR's unique technology provides surgeons and medical professionals with a new and better way of developing their skills. Importantly, it also provides companies with data on skills and usage of their products, enabling acceleration of the safe and compliant use of their products.

 

Tern CEO, Al Sisto, said, "FundamentalVR continues to expand its market presence through its complementary haptic-based simulation platforms and we congratulate the FundamentalVR team on this additional contract win. FundamentalVR's award-winning technology will be employed by this pharmaceutical company to drive the uptake of its products, highlighting the broad array of medical markets available to our portfolio company. Importantly, the FundamentalVR team is ideally positioned to execute on this potential multi-phase project following its recent fundraise which saw investment from well-regarded institutions. We look forward to reporting on the future growth of this exciting business, as well as our other portfolio companies."

 

**ENDS**

Enquiries

Tern plc

Al Sisto, CEO

Sarah Payne, Finance Director

 

Via Newgate Communications

 

Allenby Capital Limited

(Nomad and Joint broker)

David Worlidge/Alex Brearley

 

 

Tel: 0203 328 5656

 

Whitman Howard

(Joint broker)

Nick Lovering/Christopher Furness

 

 

Tel: 020 7659 1234

 

Newgate Communications

PR

Elisabeth Cowell/Megan Kovach

 

Tel: 020 3757 6880

 


ISIN:GB00BFPMV798
Category Code:MSCM
TIDM:TERN
LEI Code:2138005F87SODHL9CQ36
Sequence No.:33120
EQS News ID:927543
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
18th May 20212:05 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
18th May 202111:05 amRNSSecond Price Monitoring Extn
18th May 202111:00 amRNSPrice Monitoring Extension
18th May 20219:05 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
17th May 20219:05 amRNSSecond Price Monitoring Extn
17th May 20219:00 amRNSPrice Monitoring Extension
17th May 20217:00 amRNSNotice of General Meeting
14th May 20214:40 pmRNSSecond Price Monitoring Extn
14th May 20214:35 pmRNSPrice Monitoring Extension
10th May 20214:41 pmRNSSecond Price Monitoring Extn
10th May 20214:35 pmRNSPrice Monitoring Extension
10th May 202111:05 amRNSSecond Price Monitoring Extn
10th May 202111:00 amRNSPrice Monitoring Extension
10th May 20219:05 amRNSSecond Price Monitoring Extn
10th May 20219:00 amRNSPrice Monitoring Extension
10th May 20217:00 amRNSInvestor webinar recording
7th May 20214:40 pmRNSSecond Price Monitoring Extn
7th May 20214:35 pmRNSPrice Monitoring Extension
5th May 20219:05 amRNSSecond Price Monitoring Extn
5th May 20219:00 amRNSPrice Monitoring Extension
4th May 20214:34 pmRNSResult of AGM
4th May 20217:00 amRNSAGM Statement
21st Apr 20214:41 pmRNSSecond Price Monitoring Extn
21st Apr 20214:35 pmRNSPrice Monitoring Extension
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:36 pmRNSPrice Monitoring Extension
13th Apr 20212:06 pmRNSSecond Price Monitoring Extn
13th Apr 20212:00 pmRNSPrice Monitoring Extension
13th Apr 202111:05 amRNSSecond Price Monitoring Extn
13th Apr 202111:00 amRNSPrice Monitoring Extension
13th Apr 20219:05 amRNSSecond Price Monitoring Extn
13th Apr 20219:00 amRNSPrice Monitoring Extension
6th Apr 20214:40 pmRNSSecond Price Monitoring Extn
6th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20212:06 pmRNSSecond Price Monitoring Extn
6th Apr 20212:00 pmRNSPrice Monitoring Extension
31st Mar 20217:01 amRNSDA convertible loan note maturity date extension
31st Mar 20217:00 amRNSFinal results for the year ended 31 December 2020
29th Mar 20213:40 pmRNSAIM Director Disclosure Update
29th Mar 20212:00 pmRNSPrice Monitoring Extension
25th Mar 202111:00 amRNSPrice Monitoring Extension
24th Mar 20212:06 pmRNSSecond Price Monitoring Extn
24th Mar 20212:00 pmRNSPrice Monitoring Extension
18th Mar 20214:41 pmRNSSecond Price Monitoring Extn
18th Mar 20214:35 pmRNSPrice Monitoring Extension
18th Mar 20212:06 pmRNSSecond Price Monitoring Extn
18th Mar 20212:00 pmRNSPrice Monitoring Extension
18th Mar 202111:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.